Clinical Trials Browser

Phase 2 × Cytokine Release Syndrome × talquetamab × Clear all

NCT05972135 2026-04-22

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Phase 2 Recruiting

Cytokine Release Syndrome, Multiple Myeloma